RE: EU/UK imminent18 Dec 2021 13:44
I too had expected an announcement by now - picking up on Ken James enthusiasm a while back when he mentioned we can expect more announcements this year (ok it's true that there are a few days left). As usual with FUM, or more likely James Barder, they let things drift in my opinion.
The tie-ups this year with Atlantis, serving China and S.E Asia; Labatec Pharma, serving Middle East
; M8 Pharmaceuticals, serving Brazil and Mexico all sound amazingly positive but the real attainment this year was the CE mark from the European Union. Since when we've heard nothing from FUM except there is at last a website - but this is nothing more than a tease really. No wonder the shareprice drifts and currently well below the last placing of 40p.
I can't follow the logic of doing nothing (or appearing to me as doing nothing) - they have the cash (£12.6m as of 30th June). I'm assuming that by now they have the few trial participants that were required by the FDA, so that we're now eating into the maximum 6 months that the trial period was to run - are they waiting for the FDA to complete before acting in the EU/UK ?
They have the new non-exec Jeff Needham who will be good on advising US marketing and the other new non-exec Andrew Unitt commences 1st Jan. His experience with Boots could be useful but isn't vital. I'm impatient yes - but hen don't see why as a LT shareholder I shouldn't be. We've been through a lot of ups and downs, placings etc, particularly the recent one where we're unnecessarily under water.
Bucolic - I've unfiltered you - I'm sorry for my haste. Well done getting rid of LB.